Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Mycospor

Known as: Canesten brand of bifonazole 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
New three-dimensionally-structured hybrid phospholipid vesicles, able to load clotrimazole in a high amount (10 mg/mL), were… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2017
2017
&NA; Vaginal semisolid products are frequently used to treat vaginal infections and atrophy‐related symptoms of menopause… Expand
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2011
2011
Jojoba oil-based emulgel formulations were prepared using different concentrations of various gelling agents, such as… Expand
  • table I
  • figure 1
  • figure 1
  • table II
  • table III
Is this relevant?
1984
1984
12 patients with tinea palmaris were treated with Mycospor (Bifonazole); the average persistence of disease was 10.5 years and… Expand
Is this relevant?
1984
1984
Bifonazole (Bay h 4502, Mycospor) and clotrimazole (Bay b 5097, Canesten) are potent inhibitors of ergosterol synthesis in yeasts… Expand
Is this relevant?
1983
1983
The in vitro activity of 1-[(4-Biphenylyl)-phenylmethyl]-1H-imidazole bifonazole, Bay h 4502, Mycospor) a new antifungal… Expand
Is this relevant?
1983
1983
1-[(4-Biphenylyl)-phenylmethyl]-1H-imidazole (bifonazole, Bay h 4502, Mycospor) preferentially inhibited yeast-hypha conversion… Expand
Is this relevant?
1983
1983
The new imadozolyl derivative 1-(p, alpha-diphenyl-benzyl)imidazole (bifonazole, Bay h 4502, Mycospor) shows in vitro the broad… Expand
Is this relevant?
1983
1983
[14C]Bifonazole (1-[(4-Biphenylyl)-phenylmethyl]-1H-imidazole, Bay h 4502, Mycospor) was administered systemically (i.v.) and… Expand
Is this relevant?
1983
1983
1-[(4-Biphenylyl)-phenylmethyl]-1H-imidazole (bifonazole, Bay h 4502, Mycospor) showed in vitro significant inhibitory activity… Expand
Is this relevant?